156 related articles for article (PubMed ID: 11704297)
1. The levels of soluble amyloid beta in different high density lipoprotein subfractions distinguish Alzheimer's and normal aging cerebrospinal fluid: implication for brain cholesterol pathology?
Koudinov AR; Berezov TT; Koudinova NV
Neurosci Lett; 2001 Nov; 314(3):115-8. PubMed ID: 11704297
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's amyloid beta interaction with normal human plasma high density lipoprotein: association with apolipoprotein and lipids.
Koudinov AR; Berezov TT; Kumar A; Koudinova NV
Clin Chim Acta; 1998 Feb; 270(2):75-84. PubMed ID: 9544446
[TBL] [Abstract][Full Text] [Related]
3. Biochemical characterization of Alzheimer's soluble amyloid beta protein in human cerebrospinal fluid: association with high density lipoproteins.
Koudinov AR; Koudinova NV; Kumar A; Beavis RC; Ghiso J
Biochem Biophys Res Commun; 1996 Jun; 223(3):592-7. PubMed ID: 8687441
[TBL] [Abstract][Full Text] [Related]
4. [Beta amyloid in blood and cerebrospinal fluid is associated with high density lipoproteins].
Kudinova NV; Kudinov AR; Berezov TT
Vopr Med Khim; 1996; 42(3):253-62. PubMed ID: 9139461
[TBL] [Abstract][Full Text] [Related]
5. Possible link between lipid metabolism and cerebral amyloid angiopathy in Alzheimer's disease: A role for high-density lipoproteins?
Mulder M; Terwel D
Haemostasis; 1998; 28(3-4):174-94. PubMed ID: 10420065
[TBL] [Abstract][Full Text] [Related]
6. Soluble LR11 competes with amyloid β in binding to cerebrospinal fluid-high-density lipoprotein.
Yano K; Hirayama S; Misawa N; Furuta A; Ueno T; Motoi Y; Seino U; Ebinuma H; Ikeuchi T; Schneider WJ; Bujo H; Miida T
Clin Chim Acta; 2019 Feb; 489():29-34. PubMed ID: 30448281
[TBL] [Abstract][Full Text] [Related]
7. Serum amyloid A (SAA)-induced remodeling of CSF-HDL.
Miida T; Yamada T; Seino U; Ito M; Fueki Y; Takahashi A; Kosuge K; Soda S; Hanyu O; Obayashi K; Miyazaki O; Okada M
Biochim Biophys Acta; 2006 Apr; 1761(4):424-33. PubMed ID: 16651021
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid-induced retardation of amyloid β aggregation correlates with Alzheimer's disease and the APOE ε4 allele.
Padayachee ER; Zetterberg H; Portelius E; Borén J; Molinuevo JL; Andreasen N; Cukalevski R; Linse S; Blennow K; Andreasson U
Brain Res; 2016 Nov; 1651():11-16. PubMed ID: 27653981
[TBL] [Abstract][Full Text] [Related]
9. Cerebrovascular transport of Alzheimer's amyloid beta and apolipoproteins J and E: possible anti-amyloidogenic role of the blood-brain barrier.
Zlokovic BV
Life Sci; 1996; 59(18):1483-97. PubMed ID: 8890929
[TBL] [Abstract][Full Text] [Related]
10. Differences in the Abeta40/Abeta42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype.
Fagan AM; Younkin LH; Morris JC; Fryer JD; Cole TG; Younkin SG; Holtzman DM
Ann Neurol; 2000 Aug; 48(2):201-10. PubMed ID: 10939571
[TBL] [Abstract][Full Text] [Related]
11. Effect of the ABCA1 agonist CS-6253 on amyloid-β and lipoprotein metabolism in cynomolgus monkeys.
Noveir SD; Kerman BE; Xian H; Meuret C; Smadi S; Martinez AE; Johansson J; Zetterberg H; Parks BA; Kuklenyik Z; Mack WJ; Johansson JO; Yassine HN
Alzheimers Res Ther; 2022 Jun; 14(1):87. PubMed ID: 35751102
[TBL] [Abstract][Full Text] [Related]
12. Reconstituted high-density lipoproteins acutely reduce soluble brain Aβ levels in symptomatic APP/PS1 mice.
Robert J; Stukas S; Button E; Cheng WH; Lee M; Fan J; Wilkinson A; Kulic I; Wright SD; Wellington CL
Biochim Biophys Acta; 2016 May; 1862(5):1027-36. PubMed ID: 26454209
[TBL] [Abstract][Full Text] [Related]
13. Predominant apolipoprotein J exists as lipid-poor mixtures in cerebrospinal fluid.
Suzuki T; Tozuka M; Kazuyoshi Y; Sugano M; Nakabayashi T; Okumura N; Hidaka H; Katsuyama T; Higuchi K
Ann Clin Lab Sci; 2002; 32(4):369-76. PubMed ID: 12458888
[TBL] [Abstract][Full Text] [Related]
14. The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma.
Koudinov A; Matsubara E; Frangione B; Ghiso J
Biochem Biophys Res Commun; 1994 Dec; 205(2):1164-71. PubMed ID: 7802646
[TBL] [Abstract][Full Text] [Related]
15. The small HDL particle hypothesis of Alzheimer's disease.
Martinez AE; Weissberger G; Kuklenyik Z; He X; Meuret C; Parekh T; Rees JC; Parks BA; Gardner MS; King SM; Collier TS; Harrington MG; Sweeney MD; Wang X; Zlokovic BV; Joe E; Nation DA; Schneider LS; Chui HC; Barr JR; Han SD; Krauss RM; Yassine HN
Alzheimers Dement; 2023 Feb; 19(2):391-404. PubMed ID: 35416404
[TBL] [Abstract][Full Text] [Related]
16. Receptor binding of an apolipoprotein E-rich subfraction of high density lipoprotein to rat and human brain membranes.
Stewart JE; Skinner ER; Best PV
Int J Biochem Cell Biol; 1998 Mar; 30(3):407-15. PubMed ID: 9611781
[TBL] [Abstract][Full Text] [Related]
17. Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease.
Zimetti F; Caffarra P; Ronda N; Favari E; Adorni MP; Zanotti I; Bernini F; Barocco F; Spallazzi M; Galimberti D; Ricci C; Ruscica M; Corsini A; Ferri N
J Alzheimers Dis; 2017; 55(1):315-320. PubMed ID: 27662294
[TBL] [Abstract][Full Text] [Related]
18. Functional and structural properties of lipid-associated apolipoprotein J (clusterin).
Calero M; Tokuda T; Rostagno A; Kumar A; Zlokovic B; Frangione B; Ghiso J
Biochem J; 1999 Dec; 344 Pt 2(Pt 2):375-83. PubMed ID: 10567218
[TBL] [Abstract][Full Text] [Related]
19. Dissociation of β-amyloid from lipoprotein in cerebrospinal fluid from Alzheimer's disease accelerates β-amyloid-42 assembly.
Takamura A; Kawarabayashi T; Yokoseki T; Shibata M; Morishima-Kawashima M; Saito Y; Murayama S; Ihara Y; Abe K; Shoji M; Michikawa M; Matsubara E
J Neurosci Res; 2011 Jun; 89(6):815-21. PubMed ID: 21394760
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E: binding to soluble Alzheimer's beta-amyloid.
Wisniewski T; Golabek A; Matsubara E; Ghiso J; Frangione B
Biochem Biophys Res Commun; 1993 Apr; 192(2):359-65. PubMed ID: 8484748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
